DIAZOXIDE AND THE TREATMENT OF HYPOGLYCEMIA: AN HISTORICAL REVIEW
1968; Wiley; Volume: 150; Issue: 2 Linguagem: Inglês
10.1111/j.1749-6632.1968.tb19045.x
ISSN1749-6632
Autores Tópico(s)Erythrocyte Function and Pathophysiology
ResumoAnnals of the New York Academy of SciencesVolume 150, Issue 2 p. 194-203 DIAZOXIDE AND THE TREATMENT OF HYPOGLYCEMIA: AN HISTORICAL REVIEW Jack Black, Jack Black Schering Corporation, Bloomfield, N. J. Warner-Lambert Research Institute, Morris Plains, N. J.Search for more papers by this author Jack Black, Jack Black Schering Corporation, Bloomfield, N. J. Warner-Lambert Research Institute, Morris Plains, N. J.Search for more papers by this author First published: April 1968 https://doi.org/10.1111/j.1749-6632.1968.tb19045.xCitations: 39 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Domagk, G. 1935. Ein beitrag zur chemotherapie der bakteriellen infektionen. Deut. Med. Wochschr. 61: 250– 273. 2 Trefouel, J., Mme. J. Tkefouel, F. Nitti & D. Bovet 1935. Action of p-aminophenylsulfamide in experimental streptococcus infections. C. R. Soc. Biol. 120: 756– 758. 3 Colebrook, L. & M. Kenny 1936. Treatment of human pueperal infections and of experimental infections in mice, with Prontosil. Lancet I: 1279– 1286. 4 Buttle, G. A. H., W. H. Gray & D. Stephenson 1936. Protection of mice against streptococcal and other infections by p-aminophenylsulfamide and related substances. Lancet I: 1286– 1290. 5 Whitby, L. E. H. 1938. Chemotherapy of pneumococcal and other infections with 2-(p-aminobenzenesulfonamide) pyridine. Lancet I: 1210– 1212. 6 Raizis, G. W., M. Severac & J. C. Moetsch 1937. Chemotherapeutic studies of sulfamidyl (p-aminobenzenesulfonamide) in experimental B-hemolytic streptococcic infection. J. Chemotherapy 14: 1– 11. 7 Halpern, B. N. & R. L. Mayer 1937. Toxicities of some antistreptoccic substances. Presse Med. 45: 747– 749. 8 Marshall, E. K. Jr., W. C. Cutting & K. Emerson, Jr. 1938. The toxicity of sulfanilamide. J. Am. Med. Assoc. 110: 252– 257. 9 Ruiz, C. L., L. L. Silva & L. Libenson 1930. Contributión al estudio sobre la composición quimica de la insulina. Estudio de algunos cuerpos sinteticas solfurados con accion hypoglucemiante. Rev. Soc. argent. Biol. 6: 134– 141. cf. Duncan, L. J. P. & J. D. Baird. 1960. Compounds administered orally in the treatment of diabetes mellitus. Pharmacol. Rev. Rev: 91–158 (Reference 349). 10 Janbon, M., J. Chaptal, A. Vedel & J. Schaap 1942. Accidents hypoglycémiques graves par un sulfamidothiazol (le VK. 57 ou 2254 RP). Montpellier Méd. 21– 22: 441–444. cf. Duncan & Baird above (Reference 201). 11 Loubatières, A. 1946. Physiologie et pharmacodynamie de certains dérivés sulfamidés hypoglycémiants. Contribution à l'ètude des substances synthétiques à tropisme endocrinien. Thèse, Montpellier No. 86. Causse, Graille & Castelnau. Montpellier , France . 12 Loubatières, A. 1955. Action curative du p-amino-benzène-sulfamido-isopropylthiodiazol dans le diabète sucré humain. C. R. Acad. Sci. Paris 241: 1422– 1423. cf. Duncan & Baird above (Reference 243). 13 Mann, T. & D. Keilin 1940. Sulfanilamide as specific inhibitor of carbonic anhydrase. Nature, London 146: 164– 165. 14 Pitts, R. F. & R. S. Alexander 1945. Nature of renal tubular mechanism for acidifying urine. Am. J. Physiol. 144: 239– 254. 15 Schwartz, W. B. 1949. The effect of sulfanilamide on salt and water excretion in congestive heart failure. New England J. Med. 240: 173– 177. 16 Roblin, R. O., Jr & J. W. Clapp 1950. The preparation of heterocyclic sulfotiamides. J. Am. Chem. Soc. 72: 4890– 4892. 17 Miller, W. H., A. M. Dessert & R. O. Roblin, Jr 1950. Heterocyclic sulfonamides as carbonic anhydrase inhibitors. J. Am. Chem. Soc. 72: 4893– 4896. 18 Novello, F. C. & J. M. Sprague 1957. Benzothiadiazine dioxides as novel diuretics. J. Am. Chem. Soc. 79: 2028– 2029. 19 Ford, R. V., J. H. Moyer & C. L. Spurr 1957. Clinical and laboratory observations on chlorothiazide (Diuril). An orally effective non-mercurial diuretic agent. A.M.A. Arch. Internal. Med. 100: 582– 596. 20 Beyer, K. H., J. E. Baer, H. F. Russo & A. S. Haimbach 1957. Chlorothiazide (6-chloro-7-sulfamyl-1,2,4-benzothiadiazine-1,1–dioxide): The enhancement of sodium chloride excretion. Federation Proc. 16: 282. 21 Baer, J. E., L. Leidy & A. V. Brooks 1957. Physiological disposition of chlorothiazide (6-chloro-7-sulfamyl-1,2,4-benzothiadiazine-1.1-dioxide), a saluretic-diuretic agent. Federation Proc. 16: 278. 22 Maren, T. H., A. L. Parcell & M. N. Malik 1960. A kinetic analysis of carbonic an-hydrase inhibition. J. Pharmacol. Exp. Therap. 130: 389– 400. 23 Wilkins, R. W. 1959. New drugs for treatment of hypertension. Ann. Internal Med. 50: 1– 10. 24 Finnerty, F. A. 1959. Hypertension: The First Hahnemann Symposium on Hypertensive Disease. John Moyer, Ed., : 653. Saunders, 1959. 25 Goldner, M. G., H. Zarowitz & S. Akgun 1960. Hyperglycemia and glycosuria due to thiazide derivatives administered in diabetes mellitus. New England J. Med. 262: 403– 405. 26 Laragh, J. H. & F. E. Demartini 1957. Chlorothiazide in the management of edema of heart failure, nephrosis, and cirrhosis, (abst.) Circulation 16: 904. 27 Hollander, W., R. N. Kaplan & A. V. Chobanian 1962. The anti-hypertensive action of diazoxide, a non-diuretic benzothiadiazine. Federation Proc. 21: 178. 28 Hollander, W., A. V. Chobanian & R. W. Wilkins 1960. The role of diuretics in the management of hypertension. Ann. N. Y. Acad. Sci. 88: 975– 989. 29 Rubin, A. A., F. E. Roth, M. M. Winbury, J. G. Topliss, M. H. Sherlock, N. Sperber & J. Black 1961. New class of antihypertensive agents. Science 133: 2067. 30 Taylor, R. M., R. M. Milton, M. J. Powers & M. M. Winbury 1961. Renal pharmacology of an antihypertensive des-sulfamyl benzothiadiazine. The Pharmacologist 2: 58. 31 Pechet, M. M. ( Unpublished data). 32 Eggert, M. ( Unpublished data). 33 Marriot, H. ( Unpublished data). 34 Okun, R., R. P. Russell & W. R. Wilson 1963. Use of diazoxide with trichlormethiazide for hypertension. Arch Inter. Med. 112: 882– 888. 35 Tabachnick, I.I. A. ( Unpublished data). 36 Tabachnick, I.I. A., A. Gulbenkian & F. Seidman 1964. The effect of a benzothiadiazine diazoxide, on carbohydrate metabolism. Diabetes 13: 408– 418. 37 Fajans, S. S., J. C. Floyd, Jr., R. F. Knopf, J. Rull, E. M. Guntsche & J. W. Conn 1966. Benzothiadiazine suppression of insulin release from normal and abnormal islet tissue in man. J. Clin. Invest. 45: 481– 492. 38 Graber, A. L., D. Porte Jr. & R. H. Williams 1965. Mechanism of diazoxide hyperglycemia. Presented at the American Diabetes Association Meeting, June 1965, Hotel Roosevelt, New York , N. Y . 39 Seltzer, H. S. & E. W. Allen 1966. Inhibition of insulin secretion by diazoxide and epinephrine. Presented at the Southern Society for Clinical Research, New Orleans, La., January 1966, (abst.). Clin. Res. 14: 101. 40 Schultz, G., G. Senft, W. Losert & R. Sitt 1966. Biochemical principles of diazoxide hyperglycemia. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol. 253: 372– 387. 41 Loubatières, A., M. M. Mariani, G. Ribes & H. De Malbosc 1966. Etude expérimentale d'un sulfamide hyperglycemiant, le diazoxide. C. R. Soc. Biol. 160: 165– 168. 42 Staquet, M., R. Yabo, J. Viktora & F. Wolff 1965. An adrenergic mechanism for hyperglycemia induced by diazoxide. Metabolism 14: 1000– 1009. 43 Dollery, C. T., B. L. Pentecost & N. A. Samaan 1962. Drug-induced diabetes. Lancet. 2: 735– 737. 44 Drash, A. & F. Wolff 1964. Drug therapy in leudne-sensitive hypoglycemia. Metabolism 13: 487– 492. 45 Conway, J. ( Unpublished data). 46 Wilson, W. R., D. B. Stone, R. Okun & R. P. Russell 1964. Metabolic effects of diuretic and nondiuretic benzothiadiazines. (abst.) Ann. Int. Med. 60: 317. Citing Literature Volume150, Issue2Diazozide and the Treament of HypoglycemiaApril 1968Pages 194-203 ReferencesRelatedInformation
Referência(s)